XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Balance at beginning of period, (in shares) at Dec. 31, 2020   113,128,000      
Balance at beginning of period at Dec. 31, 2020 $ 1,205,289 $ 113 $ 1,179,972 $ (4,732) $ 29,936
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 598,626       598,626
Other comprehensive income (loss) (17,890)     (17,890)  
Dividends declared (170,679)       (170,679)
Net issuances of restricted stock (in shares)   701,000      
Net issuances of restricted stock 0 $ 1 (1)    
Stock-based compensation expense 55,932   55,932    
Repurchases of common stock, (in shares)   (3,143,000)      
Repurchases of common stock (290,227) $ (3)     (290,224)
Balance at end of period, (in shares) at Dec. 31, 2021   110,686,000      
Balance at end of period at Dec. 31, 2021 1,381,051 $ 111 1,235,903 (22,622) 167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 657,919       657,919
Other comprehensive income (loss) (21,001)     (21,001)  
Dividends declared (189,266)       (189,266)
Net issuances of restricted stock (in shares)   693,000      
Net issuances of restricted stock 0 $ 1 (1)    
Stock-based compensation expense 57,663   57,663    
Repurchases of common stock, (in shares)   (3,681,000)      
Repurchases of common stock $ (317,808) $ (4)     (317,804)
Balance at end of period, (in shares) at Dec. 31, 2022 107,698,498 107,698,000      
Balance at end of period at Dec. 31, 2022 $ 1,568,558 $ 108 1,293,565 (43,623) 318,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 411,146       411,146
Other comprehensive income (loss) 10,997     10,997  
Dividends declared (206,043)       (206,043)
Net issuances of restricted stock (in shares)   889,000      
Net issuances of restricted stock 0 $ 1 (1)    
Stock-based compensation expense 61,139   61,139    
Repurchases of common stock, (in shares)   (3,378,000)      
Repurchases of common stock $ (257,446) $ (4)     (257,442)
Balance at end of period, (in shares) at Dec. 31, 2023 105,208,817 105,209,000      
Balance at end of period at Dec. 31, 2023 $ 1,588,351 $ 105 $ 1,354,703 $ (32,626) $ 266,169